Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer

Tiriac, Hervé, Belleau, Pascal, Engle, Dannielle D., Plenker, Dennis, Deschênes, Astrid, Somerville, Tim D. D., Froeling, Fieke E. M., Burkhart, Richard A. +62 more·2018·Cancer Discovery

DOI 10.1158/2159-8290.cd-18-0349

Cited by (1,001)

Items 101–200 of 1,001

3D approaches to model the tumor microenvironment of pancreatic cancer
Elena Tomás Bort, Markus Kieler, Shreya Sharma, Juliana B. Candido, Daniela Loessner · 2020 · Theranostics
Complete regression of advanced pancreatic ductal adenocarcinomas upon combined inhibition of EGFR and C-RAF
Blasco, María Teresa, Navas, Carolina, Martín-Serrano, Guillermo, Graña-Castro, Osvaldo, Lechuga, Carmen G., Martín-Díaz, Laura, Djurec, Magdolna, Li, Jing, Morales-Cacho, Lucia, Esteban-Burgos, Laura et al. · 2019 · Cancer Cell
Why is pancreatic cancer so deadly? The pathologist's view
Hruban, Ralph H, Gaida, Matthias M, Thompson, Elizabeth, Hong, Seung‐Mo, Noë, Michaël, Brosens, Lodewijk AA, Jongepier, Martine, Offerhaus, G Johan A, Wood, Laura D · 2019 · The Journal of Pathology
Functional precision oncology using patient-derived assays: bridging genotype and phenotype
Allard W. J. van Renterghem, Joris van de Haar, Emile E. Voest · 2023 · Nature Reviews Clinical Oncology
Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma
Loryn L. Holokai, Jayati L. Chakrabarti, Joanne Lundy, Daniel Gerald Croagh, Pritha Adhikary, Scott S. Richards, Chantal Woodson, Nina G. Steele, Robert K. Kuester, Aaron James Scott et al. · 2020 · Cancers
Discovery of a selective inhibitor of doublecortin like kinase 1
Fleur M. Ferguson, Behnam Nabet, Srivatsan Raghavan, Yan Liu, Alan L. Leggett, Miljan Kuljanin, Radha L. Kalekar, Annan Yang, Shuning He, Jinhua Wang et al. · 2020 · Nature Chemical Biology
Cancer organoid co-culture model system: Novel approach to guide precision medicine
Jin Yuan, Xiao-Yang Li, Sheng-Ji Yu · 2023 · Frontiers in Immunology
Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
Xiang, Dongxi, He, Aina, Zhou, Rong, Wang, Yonggang, Xiao, Xiuying, Gong, Ting, Kang, Wenyan, Lin, Xiaolin, Wang, Xiaochen, PDO-based DST Consortium11 et al. · 2024 · Theranostics
Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
Marcel Alexander Heinrich, Ahmed M. R. H. Mostafa, Jennifer P. Morton, Lukas J.A.C. Hawinkels, Jai Prakash · 2021 · Advanced Drug Delivery Reviews
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
Jarle Bruun, Kushtrim Kryeziu, Peter W. Eide, Seyed H. Moosavi, Ina Andrassy Eilertsen, Jonas Langerud, Bård Ingvald Røsok, Max Zachrisson Totland, Tuva Høst Brunsell, Teijo S. Pellinen et al. · 2020 · Clinical Cancer Research
Bladder cancer organoids as a functional system to model different disease stages and therapy response
Martina Minoli, Thomas Cantore, Daniel Hanhart, Mirjam Kiener, Tarcisio Fedrizzi, Federico La Manna, Sofia Karkampouna, Panagiotis Chouvardas, Vera Genitsch, Antonio Rodríguez-Calero et al. · 2023 · Nature Communications
A pan-cancer organoid platform for precision medicine
Larsen, Brian M., Kannan, Madhavi, Langer, Lee F., Leibowitz, Benjamin D., Bentaieb, Aicha, Cancino, Andrea, Dolgalev, Igor, Drummond, Bridgette E., Dry, Jonathan R., Ho, Chi-Sing et al. · 2021 · Cell Reports
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
Franziska Haderk, Yu‐Ting Chou, Lauren Čech, Celia Fernández-Méndez, Johnny X. Yu, Victor R. Olivas, Ismail Mustafa Meraz, Dora Barbosa Rabago, Daniel Lucas Kerr, Carlos F. Gómez et al. · 2024 · Nature Communications
Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy
Else Driehuis, Sacha Spelier, Irati Beltrán Hernández, Remco de Bree, Stefan M. Willems, Hans C. Clevers, Sabrina Oliveira · 2019 · Journal of Clinical Medicine
Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer
Alice Boilève, Jérôme Cartry, Negaar Goudarzi, Sabrina Bedja, Jacques R.R. Mathieu, Mohamed Amine Bani, Rémy Nicolle, Ali Mouawia, Ryme Bouyakoub, Claudio Nicotra et al. · 2024 · Gastroenterology
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer
Jessica Kristine Nelson, May Zaw Thin, Theodore Evan, Steven A. Howell, Mary Wu, Bruna Almeida, Nathalie Michelle Legrave, Duco Steven Koenis, Gabriela Koifman, Yoichiro Sugimoto et al. · 2022 · Nature Communications
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
Alexander Biederstädt, Zonera Hassan, Christian Schneeweis, Markus Schick, Lara Schneider, Alexander Muckenhuber, Ying‐Fen Hong, Gerrit Siegers, Lisa M. Nilsson, Matthias Wirth et al. · 2020 · Gut
Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer
Xiuchao Wang, Yunzhan Li, Zekun Li, Shengchen Lin, Hongwei Wang, Jianwei Sun, Chungen Lan, Liangliang Wu, Dongxiao Sun, Chongbiao Huang et al. · 2022 · Cancer Research
Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer
Yi Zhao, Shangru Li, Lefan Zhu, Mingle Huang, Yubin Xie, Xinming Song, Zhihui Chen, Harry Cheuk-Hay Lau, Joseph Jao-Yiu Sung, Lixia Xu et al. · 2024 · Cell Reports Medicine
Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity
Xiaohan Shi, Yunguang Li, Qiuyue Yuan, Shijie Tang, Shiwei Guo, Yehan Zhang, Juan He, Xiaoyu Zhang, Ming Han, Zhuang Liu et al. · 2022 · Nature Communications
Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression
Shengchen Lin, Yunzhan Li, Dezhen Wang, Chongbiao Huang, David Marino, Oana Bollt, Chaodong Wu, Matthew D. Taylor, Wei Li, Gina M. DeNicola et al. · 2021 · Cancer Letters
Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
Ren‐Bo Ding, Ping Chen, Barani Kumar Rajendran, Xueying Lyu, Haitao Wang, Jiaolin Bao, Jianming Zeng, Wenhui Hao, Heng Sun, Ada Hang‐Heng Wong et al. · 2021 · Nature Communications
Single-cell-resolved differentiation of human induced pluripotent stem cells into pancreatic duct-like organoids on a microwell chip
Sandra Wiedenmann, Markus Breunig, Jessica Merkle, Christine von Toerne, Tihomir Georgiev, Michel Moussus, Lucas-Alexander Schulte, Thomas Theodor Werner Seufferlein, Michael Sterr, Heiko Lickert et al. · 2021 · Nature Biomedical Engineering
iPSC-derived and Patient-Derived Organoids: Applications and challenges in scalability and reproducibility as pre-clinical models
Elisa Heinzelmann, Francesco Piraino, Mariana Costa, Aline Roch, Maxim N. Norkin, Virginie Garnier, Krisztián Homicskó, Nathalie Brandenberg · 2024 · Current Research in Toxicology
Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship
Giulia Gasparini, Marta Pellegatta, Stefano Crippa, Marco Schiavo Lena, Giulio Belfiori, Claudio Doglioni, Carla Taveggia, Massimo Falconi · 2019 · Cancers
Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling
Su Kyeom Kim, Yu Heun Kim, Sewon Park, Seung‐Woo Cho · 2021 · Acta Biomaterialia
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
Toni T. Seppälä, Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs, Christopher R. Shubert, John L. Cameron, William R. Burns, Kelly J. Lafaro et al. · 2022 · Clinical Cancer Research
Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy
Lyudmyla Demyan, Amber N. Habowski, Dennis Plenker, Daniel A. King, Oliver J. Standring, Caitlin Tsang, Luce St. Surin, Arvind Rishi, James M. Crawford, Jeff Boyd et al. · 2022 · Annals of Surgery
Engineering approaches for studying immune-tumor cell interactions and immunotherapy
Shelton, Sarah E., Nguyen, Huu Tuan, Barbie, David A., Kamm, Roger D. · 2021 · iScience
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Malia Alexandra Foo, Ming You, Shing Leng Chan, Gautam Sethi, Glenn Kunnath Bonney, Wei Peng Yong, Edward Kai‐Hua Chow, Eliza Li Shan Fong, Lingzhi Wang, Boon-Cher Goh · 2022 · Biomarker Research
Systemic Therapy for Metastatic Pancreatic Cancer
Thomas Jens Ettrich, Thomas Theodor Werner Seufferlein · 2021 · Current Treatment Options in Oncology
The next wave of cellular immunotherapies in pancreatic cancer
Dannel Yeo, Caroline Giardina, Payal Saxena, John E.J. Rasko · 2022 · Molecular Therapy — Oncolytics
Genetics of familial and sporadic pancreatic cancer
Wood, Laura D., Yurgelun, Matthew B., Goggins, Michael G. · 2019 · Gastroenterology
Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment
Elena Maria Tosca, Davide Ronchi, Daniele Facciolo, Paolo Magni · 2023 · Biomedicines
Dual inhibition of KRASG12D and pan-ERBB is synergistic in pancreatic ductal adenocarcinoma
Gulay, Kevin Christian Montecillo, Zhang, Xinlian, Pantazopoulou, Vasiliki, Patel, Jay, Esparza, Edgar, Pran Babu, Deepa Sheik, Ogawa, Satoshi, Weitz, Jonathan, Ng, Isabella, Mose, Evangeline S. et al. · 2023 · Cancer Research
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Daisong Wang, Rémi Villenave, Nadine Stokar‐Regenscheit, Hans C. Clevers · 2025 · Nature Reviews Drug Discovery
Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma
Adam L. Burrack, Ellen J. Spartz, Jackson F. Raynor, Iris Wang, Margaret A Olson, Ingunn M. Stromnes · 2019 · Cell Reports
Cancer biology as revealed by the research autopsy
Christine A. Iacobuzio–Donahue, Chelsea Michael, Priscilla Baez, Rajya L. Kappagantula, Jody E. Hooper, Travis J. Hollman · 2019 · Nature reviews. Cancer
“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”
Federica Papaccio, Blanca García-Micó, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro‐Cervelló, Carolina Martínez‐Ciarpaglini, Pilar Rentero-Garrido, S. Zúñiga et al. · 2023 · Journal of Experimental & Clinical Cancer Research
Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models
Gang Yang, Wenfang Guan, Zhe Cao, Wenbo Guo, Guangbing Xiong, Fangyu Zhao, Mengyu Feng, Jiangdong Qiu, Yueze Liu, Michael Q. Zhang et al. · 2021 · Clinical Cancer Research
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
Talya L. Dayton, Nicolas Alcala, Laura Moonen, Lisanne den Hartigh, Veerle Geurts, Lise Mangiante, Lisa M. V. Lap, Antonella F. M. Dost, Joep Beumer, Sonja Levy et al. · 2023 · Cancer Cell
Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
Wenjie Huang, Bernat Navarro-Serer, Yea Ji Jeong, Peter E. Chianchiano, Limin Xia, Claudio Luchini, Nicola Veronese, Cameron Dowiak, Tammy Ng, María Aurora Martínez Trujillo et al. · 2020 · Cancer Research
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
Rémy Nicolle, Odile Gayet, Pauline Duconseil, Charles Vanbrugghe, Julie Roques, Martin Bigonnet, Yuna Blum, Nabila Elarouci, Lucile Armenoult, Mira Ayadi et al. · 2020 · Annals of Oncology
Neoadjuvant and adjuvant chemotherapy in pancreatic cancer
Ulla Klaiber, Carl-Stephan Leonhardt, Oliver Strobel, Christine Tjaden, Thilo Hackert, John P. Neoptolemos · 2018 · Langenbeck s Archives of Surgery
Pancreatic cancer‐derived organoids – a disease modeling tool to predict drug response
Pierre‐Olivier Frappart, Karolin Walter, Johann Gout, Alica K. Beutel, Mareen Morawe, Frank Arnold, Markus Breunig, Thomas F.E. Barth, Ralf B. Marienfeld, Lucas-Alexander Schulte et al. · 2020 · United European Gastroenterology Journal
Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer
Jialong Zhu, Linlin Ji, Yitian Chen, Huiyu Li, Mengxi Huang, Zhe Dai, Jing Wang, Dan Xiang, Gongbo Fu, Zengjie Lei et al. · 2023 · Cell Death Discovery
Pancreatic cancer–restricted cryptic antigens are targets for T cell recognition
Zackery A. Ely, Zachary J. Kulstad, Gürcan Günaydın, Sudarsana Addepalli, Eva K. Verzani, Marta Casarrubios, Karl R. Clauser, Xilin Wang, Isabelle E Lippincott, Cédric Louvet et al. · 2025 · Science
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
Jungeun Lim, Hanna Ching, Jeong‐Kee Yoon, Noo Li Jeon, YongTae Kim · 2021 · Nano Convergence
Modeling pancreatic cancer in mice for experimental therapeutics
Kavita B. Mallya, Shailendra Kumar Gautam, Abhijit Aithal, Surinder K. Batra, Maneesh Jain · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Adjuvant treatment for pancreatic cancer
Ulla Klaiber, Thilo Hackert, John P. Neoptolemos · 2019 · Translational Gastroenterology and Hepatology
Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids
Anna E. Vilgelm, Kensey N. Bergdorf, Melissa M. Wolf, Vijaya Bharti, Rebecca L. Shattuck-Brandt, Ashlyn Blevins, Caroline Y. Jones, Courtney J. Phifer, Mason A. Lee, Cindy L. Lowe et al. · 2020 · iScience
Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
Christian Hirt, Tijmen H. Booij, Linda Grob, Patrik Simmler, Nora C. Toussaint, David Keller, Doreen Taube, Vanessa Ludwig, Alexander Goryachkin, Chantal Pauli et al. · 2022 · Cell Genomics
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis
Tianxing Zhou, Yongjie Xie, Xupeng Hou, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan et al. · 2023 · Journal of Experimental & Clinical Cancer Research
Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype
Ki Oh, Yun Jae Yoo, Luke A. Torre-Healy, Manisha Rao, Danielle Fassler, Pei Wang, Michael D. Caponegro, Mei Gao, Joseph Kim, Aaron R. Sasson et al. · 2023 · Nature Communications
Newly developed 3D in vitro models to study tumor–immune interaction
Peiyuan Mu, Shujuan Zhou, Tao Lv, Fan Xia, Lijun Shen, Juefeng Wan, Yaqi Wang, Hui Zhang, Sanjun Cai, Junjie Peng et al. · 2023 · Journal of Experimental & Clinical Cancer Research
Standardization of organoid culture in cancer research
Changchun Zhou, Yuanbo Wu, Zeyu Wang, Yanli Liu, Jiaqi Yu, Weiping Wang, Sunrui Chen, Weihua Wu, Ji‐Dong Wang, Guowei Qian et al. · 2023 · Cancer Medicine
Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer
Yunguang Li, Shijie Tang, Xiaohan Shi, Jingwen Lv, Xueyuan Wu, Yehan Zhang, Huan Wang, Juan He, Yiqin Zhu, Yi Ju et al. · 2023 · Cell Reports Medicine
Organoid models for translational pancreatic cancer research
Hervé Tiriac, Dennis Plenker, Lindsey A. Baker, David Arthur Tuveson · 2019 · Current Opinion in Genetics & Development
Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Xu Zhou, Kai Hu, Peter J. Bailey, Christoph Springfeld, Susanne Roth, Roma Kurilov, Benedikt Brors, Thomas Mathias Gress, Malte Buchholz, Jingyu An et al. · 2021 · Frontiers in Cell and Developmental Biology
Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
Dan He, Huijin Feng, Belen Sundberg, Jiaxing Yang, Justin Powers, Alec H. Christian, John Erby Wilkinson, Cian Monnin, Daina Zofija Avizonis, Craig J. Thomas et al. · 2022 · Molecular Cell
Applications of human organoids in the personalized treatment for digestive diseases
Qinying Wang, Fanying Guo, Yutao Jin, Yanlei Ma · 2022 · Signal Transduction and Targeted Therapy
Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma
Maria Victoria Recouvreux, Shea F. Grenier, Yijuan Zhang, Edgar Esparza, Guillem Lambies, Cheska Marie Galapate, Swetha Maganti, Karen Duong‐Polk, Deepika Bhullar, Razia F. Naeem et al. · 2023 · Nature Cancer
Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications
Sandrina Martens, Pierre Lefesvre, Rémy Nicolle, Andrew Victor Biankin, Francesco Puleo, Jean‐Luc Van Laethem, Ilse Rooman · 2019 · Annals of Oncology
A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer
Vilma Pacheco-Barcía, Rebeca Mondéjar Solís, T. France, Jamil Asselah, Olga Donnay, George Zogopoulos, Nathaniel Bouganim, Katie Guo, Jacobo Rogado, Elena Martín et al. · 2019 · Pancreatology
Patient‐derived organoids for personalized gallbladder cancer modelling and drug screening
Bo Yuan, Xiaofang Zhao, Xiang Wang, Erdong Liu, Chunliang Liu, Yali Zong, Youhai Jiang, Minghui Hou, Yao Chen, Lei Chen et al. · 2022 · Clinical and Translational Medicine
Enabling peristalsis of human colon tumor organoids on microfluidic chips
Fang, Guocheng, Lu, Hongxu, Al-Nakashli, Russul, Chapman, Robert, Zhang, Yingqi, Ju, Lining Arnold, Lin, Gungun, Stenzel, Martina H, Jin, Dayong · 2022 · Biofabrication
Druggable genome and precision medicine in cancer: current challenges
Camille Dupont, Kristina Riegel, Malvika Pompaiah, Hartmut H. Juhl, Krishnaraj Rajalingam · 2021 · FEBS Journal
Immune organoids: from tumor modeling to precision oncology
Vinh A Dao, Kanako Yuki, Yuan‐Hung Lo, Michitaka Nakano, Calvin Jay Kuo · 2022 · Trends in cancer
ERRα promotes glycolytic metabolism and targets the NLRP3/caspase-1/GSDMD pathway to regulate pyroptosis in endometrial cancer
Pingping Su, Xiaodan Mao, Jincheng Ma, Lixiang Huang, Lirui Yu, Shuting Tang, Mingzhi Zhuang, Zhonglei Lu, Kelvin Stefan Osafo, Yuan Ren et al. · 2023 · Journal of Experimental & Clinical Cancer Research
Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer
Mans Broekgaarden, Sriram R. Anbil, Anne‐Laure Bulin, Girgis Obaid, Zhiming Mai, Yan Baglo, Imran Rizvi, Tayyaba G. Hasan · 2019 · Biomaterials
Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies
Marina Ayres Pereira, Iok In Christine Chio · 2019 · Genes
Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients
Jing‐Hua Chen, Xiangpeng Chu, Jia‐Tao Zhang, Qiang Nie, Wen‐Fang Tang, Jian Su, Hong‐Hong Yan, Hongping Zheng, Ze‐Xin Chen, Xin Chen et al. · 2020 · Thoracic Cancer
Organoid technology for tissue engineering
Juan He, Xiaoyu Zhang, Xinyi Xia, Ming Han, Fei Li, Chunfeng Li, Yunguang Li, Dong Gao · 2020 · Journal of Molecular Cell Biology
Drug screening model meets cancer organoid technology
Chen Liu, Tianyu Qin, Yuhan Huang, Yuan Li, Gang Chen, Chaoyang Sun · 2020 · Translational Oncology
Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
Henry Jeison Ruiz-Garcia, Keila Alvarado-Estrada, Paula V. Schiapparelli, Alfredo Quiñones‐Hinojosa, Daniel Michael Trifiletti · 2020 · Frontiers in Cellular Neuroscience
Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy
Daheui Choi, Alan M. Gonzalez‐Suarez, Mihai Gabriel Dumbrava, Michael J. Medlyn, José M. de Hoyos‐Vega, Frank M. Cichocki, Jeffrey S. Miller, Ding Li, Mojun Zhu, Gulnaz Stybayeva et al. · 2023 · Advanced Science
The landscape of drug sensitivity and resistance in sarcoma
Ahmad Al Shihabi, Peyton J. Tebon, Huyen Thi Lam Nguyen, Jomjit Chantharasamee, Sara Sartini, Ardalan Davarifar, Alexandra Y Jensen, Miranda B. Diaz-Infante, Hannah Cox, Alfredo Enrique Gonzalez et al. · 2024 · Cell stem cell
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
Luca Lazzari, Giorgio Corti, Gabriele Picco, Claudio Isella, Monica Montone, Pamela Arcella, Erika Durinikova, Eugenia Rosalinda Zanella, Luca Novara, Fabiane Barbosa et al. · 2019 · Clinical Cancer Research
Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer
Ledong Wan, Kuan‐Ting Lin, Mohammad Alinoor Rahman, Yuma Ishigami, Zhikai Wang, Mads Aaboe Jensen, John Erby Wilkinson, Youngkyu Park, David Arthur Tuveson, Adrian R. Krainer · 2023 · Cancer Discovery
Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responses
Ramos Zapatero, María, Tong, Alexander, Opzoomer, James W., O’Sullivan, Rhianna, Cardoso Rodriguez, Ferran, Sufi, Jahangir, Vlckova, Petra, Nattress, Callum, Qin, Xiao, Claus, Jeroen et al. · 2023 · Cell
Organoid technology in cancer precision medicine
Xinyi Xia, Fei Li, Juan He, Rebiguli Aji, Dong Gao · 2019 · Cancer Letters
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma
Swati Venkat, Arwen A. Tisdale, Johann RE Schwarz, Abdulrahman A. Alahmari, H. Carlo Maurer, Kenneth P. Olive, Kevin Hasegawa Eng, Michael E. Feigin · 2020 · Genome Research
Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy
Z. Gu, Yanli Yao, Guizhu Yang, Guo-Pei Zhu, Z. Tian, Rui Wang, Qi Wu, Yu-Jue Wang, Ya-Ping Wu, Lan Chen et al. · 2022 · Science Translational Medicine
The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response
Henry C.-H. Law, Dragana Lagundžin, Emalie J. Clement, Fangfang Qiao, Zachary S. Wagner, Kimiko L. Krieger, Diane L. Costanzo-Garvey, Thomas C. Caffrey, Jean L. Grem, Dominick J. DiMaio et al. · 2019 · Clinical Cancer Research
Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application
MoonSun Jung, Sarah Ghamrawi, Eric Yiwei Du, J. Justin Gooding, Maria Kavallaris · 2022 · Advanced Healthcare Materials
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
Lidwien Paula Smabers, G. Emerens Wensink, Carla S. Veríssimo, Esmee Koedoot, Katerina-Chara Pitsa, Maarten A. Huismans, Celia Higuera Barón, Mayke Doorn, Liselot Valkenburg‐van Iersel, Geert A. Cirkel et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses
Giulia Raimondi, Ana Mato-Berciano, Silvia Pascual-Sabater, Maria Rovira-Rigau, Míriam Cuatrecasas, Constantino Fondevila, Santiago Sánchez-Cabús, Harry Begthel, Sylvia F. Boj, Hans C. Clevers et al. · 2020 · EBioMedicine
Modelling of primary ciliary dyskinesia using patient-derived airway organoids
Jelte van der Vaart, Lena Böttinger, Maarten H. Geurts, Willine J. van de Wetering, Kèvin Knoops, Norman Sachs, Harry Begthel, Jeroen Korving, Carmen López‐Iglesias, Peter J. Peters et al. · 2021 · EMBO Reports
Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
Ergang Wang, Kun Xiang, Yun Zhang, Xiao‐Fan Wang · 2022 · Journal of the National Cancer Center
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Hao Zhang, Li Fu, Xinwen Leiliang, Chunrun Qu, Wantao Wu, Rong Wen, Ning Huang, Qiuguang He, Quan Cheng, Guodong Liu et al. · 2024 · 癌症：英文版
Patient‐derived cancer organoids for drug screening: Basic technology and clinical application
Xiaoxue Ren, Weikang Chen, Qingxia Yang, Xiaoxing Li, Lixia Xu · 2022 · Journal of Gastroenterology and Hepatology
Organotypic culture assays for murine and human primary and metastatic-site tumors
Veena Padmanaban, Eloïse M. Grasset, Neil M. Neumann, Andrew K. Fraser, Elodie Henriet, William H. Matsui, Phuoc Tho Tran, Kevin J. Cheung, Dan Georgess, Andrew J. Ewald · 2020 · Nature Protocols
One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
Geurts, Maarten H., Gandhi, Shashank, Boretto, Matteo G., Akkerman, Ninouk, Derks, Lucca L. M., van Son, Gijs, Celotti, Martina, Harshuk-Shabso, Sarina, Peci, Flavia, Begthel, Harry et al. · 2023 · Nature Communications
Recent advances in preclinical models for lung squamous cell carcinoma
Yuanwang Pan, Han Han, Kristen E. Labbe, Hua Zhang, Kwok‐Kin Wong · 2021 · Oncogene
Patient-Derived Organoids as a Model for Cancer Drug Discovery
Colin J. Rae, Francesco Amato, Chiara Braconi · 2021 · International Journal of Molecular Sciences
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Xu Zhou, Jingyu An, Roma Kurilov, Benedikt Brors, Kai Hu, Teresa Peccerella, Stephanie K. Roessler, Katrin Pfütze, Angela Schulz, Stephan Wolf et al. · 2023 · Nature Cancer
A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response
Alica K. Beutel, Lena Dorothee Schütte, Jeanette Scheible, Élodie Roger, Martin Müller, Lukas Perkhofer, Annika M. T. U. Kestler, Johann Michael Kraus, Hans Armin Kestler, Thomas F.E. Barth et al. · 2021 · Cancers
A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
Zhuolong Zhou, Kevin Van der Jeught, Yujing Li, Samantha Sharma, Tao Yu, Ishara Moulana, Sheng Liu, Jun Wan, Paul R. Territo, Mateusz Opyrchal et al. · 2023 · Advanced Science
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC
Elena Fiorini, Antonia Malinova, Daniel Schreyer, Davide Pasini, Michele Bevere, Giorgia Alessio, Diego Rosa, Sabrina L. D’Agosto, Luca Azzolin, Salvatore Milite et al. · 2025 · Nature
Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
Kostas Palamaris, Evangelos S. Felekouras, Stratigoula Sakellariou · 2021 · Cancers